Gastric Cancers Clinical Trials

7 recruiting

Gastric Cancers Trials at a Glance

7 actively recruiting trials for gastric cancers are listed on ClinicalTrialsFinder across 6 cities in 2 countries. The largest study group is Phase 2 with 2 trials, with the heaviest enrollment activity in Hangzhou, Shanghai, and Chicago. Lead sponsors running gastric cancers studies include Jichao Qin, Nanfang Hospital, Southern Medical University, and Guo ShiWei.

Browse gastric cancers trials by phase

Treatments under study

About Gastric Cancers Clinical Trials

Looking for clinical trials for Gastric Cancers? There are currently 7 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Gastric Cancers trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Gastric Cancers clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting

Tissue Procurement for Gastric Cancer, Gastrointestinal Stromal Tumors (GIST), Esophageal Cancer, Pancreas Cancer, Hepatocellular Cancer, Biliary Cancer, Neuroendocrine, Peritoneal Mesothelioma, Anal Cancer and Colorectal Cancer in Patients Undergoing Surgery or Biopsy

Gastric Cancers
University of Chicago1,000 enrolled1 locationNCT01416714
Recruiting

Analysis of Lymph Node Metastasis and Tumor Deposit in the Short Gastric Mesentery Following Total Gastrectomy for Gastric Cancer

Gastric Cancers
Jichao Qin150 enrolled1 locationNCT06728878
Recruiting
Phase 2

Robotic Gastrectomy for Locally Advanced Gastric Cancer After Neoadjuvant Therapy

Gastric Cancers
The First Affiliated Hospital with Nanjing Medical University40 enrolled1 locationNCT06895447
Recruiting
Phase 1Phase 2

QL1706 Combined With SOX Used in Theperioperative Treatment

Gastric CancersEsophagogastric Junction Cancers
Xiangdong Cheng54 enrolled1 locationNCT06766305
Recruiting

Correlation of Psychological Distress and Immune Checkpoint Inhibitors in Gastric Cancer

Gastric Cancers
Nanfang Hospital, Southern Medical University268 enrolled1 locationNCT07003334
Recruiting

Raman Spectroscopy-Based Deep Learning Model for Early Pan-Cancer Early Diagnosis

Gastric CancersEsophageal CancerCancer Screening+14 more
Second Affiliated Hospital, School of Medicine, Zhejiang University600 enrolled4 locationsNCT06822413
Recruiting
Not Applicable

AI-Assisted Non-Contrast CT for Multi-Cancer Screening

Breast CancerLung CancersLiver Cancer+4 more
Guo ShiWei1,000,000 enrolled1 locationNCT06632886